Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy (OPTILIV)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborators:
Gustave Roussy, Cancer Campus, Grand Paris
Merck Serono International SA
Pfizer
CRESGE
Information provided by (Responsible Party):
Association pour la Recherche sur le Temps Biologique et la Chronothérapie
ClinicalTrials.gov Identifier:
NCT00852228
First received: February 25, 2009
Last updated: December 10, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)